Securities code: Pharmaron Beijing Co.Ltd(300759) securities abbreviation: Pharmaron Beijing Co.Ltd(300759) Announcement No.: 2022025
Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd
Announcement on the company’s financial assistance for employees’ house purchase
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Important content tips:
1. The company plans to use its own funds to pay for those who have a doctor’s degree (including those who graduated from the doctor’s class of KANGLONG College) and rank
Regular employees below vice president who have signed a labor contract with the company and have served for one year shall provide interest free house purchase loan assistance for up to 5 years, and the personal loan limit of employees shall not exceed Shanghai Pudong Development Bank Co.Ltd(600000) yuan.
2. The financial assistance has been approved at the 18th meeting of the second board of directors and the 10th meeting of the second board of supervisors
Through deliberation at the fourth meeting, the independent directors and the recommendation institution have expressed their opinions, which do not need to be submitted to the general meeting of shareholders for deliberation, nor do they constitute related party transactions.
3. For the financial assistance, the company signed the loan contract with the employees to clarify the repayment plan and punish the violators
The contract has made detailed provisions. Although the company has taken corresponding risk control measures for this financial assistance, there are still some risks. Please pay attention to the investment risks.
Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd. (hereinafter referred to as “the company”) was established in March 2022
On June 25, the 18th meeting of the second board of directors and the 14th meeting of the second board of supervisors were held. The proposal on the company’s financial assistance for employees’ house purchase was reviewed and approved, and the company was agreed to provide interest free house purchase loan assistance for qualified employees for up to 5 years.
This financial assistance is a prudent decision made for the purpose of attracting and retaining outstanding talents of the company and its subsidiaries, which will not affect the normal business development and capital use of the company and its subsidiaries. It does not belong to the situation that financial assistance is not allowed under the provisions of Shenzhen Stock Exchange gem stock listing rules, Shenzhen Stock Exchange listed companies self regulatory guidance No. 2 – standardized operation of GEM listed companies, etc.
1、 Overview of funding matters
1. Scope of application: Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd. and its wholly-owned subsidiaries in China
subsidiary.
2. Qualification of applicants: regular employees who have a doctor’s degree (including those who graduated from the doctor’s class of KANGLONG College) and whose rank is below vicepresident, have signed a labor contract with the company and have served for more than one year, the second entry shall be calculated according to the latest entry time, and the applicant has no bad credit records and no violations of laws and disciplines.
Except directors, supervisors, senior managers, actual controllers, shareholders holding more than 5% of the company’s shares and their affiliates.
3. Loan limit: the total amount shall not exceed 10% of the latest audited net assets of the company when the loan occurs. The loan returned by the employee and the unused amount will be recycled for the subsequent application for house purchase loan of the company’s employees. The personal loan amount of employees shall not exceed Shanghai Pudong Development Bank Co.Ltd(600000) yuan. Each qualified employee can only apply for house purchase loan once in a loan cycle.
4. Source of funds: the company’s own funds.
5. Purpose of loan: the loan is used for the only commercial house purchased by the applicant in the place of work. It can be the first or improved house.
6. Loan term and repayment method: the maximum loan term shall not exceed 5 years. The loan shall be repaid in equal monthly installments from the first month after the loan, which shall be deducted from the applicant’s after tax monthly salary until it is paid off.
7. Loan interest: interest free.
8. Approval procedure: this financial assistance is within the scope of the board of directors’ deliberation authority and does not need to be submitted to the general meeting of shareholders for deliberation, nor does it constitute a connected transaction.
2、 Risk prevention measures
With regard to the loan, the company signed the loan contract with the employees to clarify the repayment plan and make detailed provisions on the breach of contract. If the loan employee leaves the company within the specified loan service period (including but not limited to resignation, no renewal or dismissal after the expiration of the labor contract), the loan employee must pay off all the loans at one time at the finance department before leaving the company. If the company or its subsidiaries fail to pay off all the loans before leaving the company, they have the right to bring a lawsuit to the court.
If an employee arbitrarily changes the purpose of the loan, checks out after obtaining the loan, makes false statements in the process of loan application or forges materials in the process of loan, is punished for violating the company’s rules and regulations, or fails to pass the annual performance assessment after loan, i.e. the grade is “d”, the company has the right to recover the loan in advance.
3、 Accumulated amount of financial assistance and overdue amount
As of the disclosure date, the total balance of financial assistance provided by the company to the outside world is RMB 0 (excluding the amount of this loan and the financial assistance provided by the company to its holding subsidiaries), and there is no overdue recovery of financial assistance.
4、 Authorization matters
Request the board of directors to authorize the company’s manager office to organize the company’s human resources department, finance department and legal department to coordinate, manage and supervise matters related to loan and repayment; And require the internal control department to include the relevant borrowing into the scope of annual internal control and supervision.
5、 Description of special opinions
1. Opinions of the board of directors
After deliberation, the board of Directors believes that the company uses part of its own funds to provide economic support for employees to buy houses without affecting its normal operation, mainly to attract and retain excellent talents of the company and its subsidiaries, promote employees to live and work in peace and contentment, improve the quality of life, and further improve the company’s welfare system and improve employees’ welfare treatment. The matter is formulated on the basis of fully considering the performance ability of employees and other factors, and the relevant risks are controllable. Therefore, the board of directors agrees that the company will provide interest free house purchase loan assistance for qualified employees for up to 5 years. 2. Opinions of the board of supervisors
The board of supervisors believes that this financial assistance is a prudent decision based on the needs of the company’s operation and development, and will not affect the normal business development and fund use of the company and its subsidiaries. It is mainly to attract and retain outstanding talents of the company and its subsidiaries, further improve the company’s welfare system and improve employee welfare, which is conducive to the long-term development of the company. The matter is formulated on the basis of fully considering the performance ability of employees and other factors, and the relevant risks are controllable. Therefore, the board of supervisors agreed to provide financial assistance for employees’ house purchase.
3. Opinions of independent directors
The company uses its own funds to provide financial assistance to regular employees with doctoral degree (including those who graduated from the doctoral class of KANGLONG College) and below the rank of vice president, who have signed labor contract with the company and have served for one year, which can further improve the employee welfare system, stimulate employees’ work enthusiasm, and better attract and retain core talents in key positions. The subsidy does not damage the legitimate rights and interests of the company and all shareholders, especially minority shareholders. The decision-making procedures of the company on this matter comply with the provisions of relevant laws, regulations, departmental rules and the articles of association. Therefore, we unanimously agree that the company will provide financial assistance for employees’ house purchase.
4. Verification opinions of the recommendation institution
After verification, the sponsor believes that the financial assistance provided by the company for employees’ house purchase has been deliberated and approved at the 18th meeting of the second board of directors and the 14th meeting of the second board of supervisors, and the independent directors have issued clear consent opinions. The financial assistance has fulfilled the necessary decision-making procedures and is in line with the stock listing rules of Shenzhen Stock Exchange The requirements of relevant laws, administrative regulations, departmental rules and business rules, such as the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM. On the premise of not affecting its normal operation, the company uses its own funds to provide financial assistance to qualified employees, which can further improve the employee welfare system and stimulate employees’ work enthusiasm. There is no situation that damages the legitimate rights and interests of the company and all shareholders, especially small and medium-sized shareholders.
In conclusion, the sponsor has no objection to the company’s financial assistance for employees’ house purchase this time
6、 Documents for future reference
1. Resolutions of the 18th meeting of the second board of directors;
2. Resolutions of the 14th meeting of the second board of supervisors;
3. Independent opinions of independent directors on matters related to the 18th meeting of the second board of directors;
4. Verification opinions of Orient Securities Company Limited(600958) underwriting sponsor Co., Ltd. on Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd. providing financial assistance for employees’ house purchase.
It is hereby announced.
Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd. board of directors March 28, 2022
